Used in pharmaceutical research as a key intermediate in the development of anti-inflammatory and analgesic agents. Its structure supports activity in modulating enzyme pathways involved in pain and swelling. Shows potential in the design of new cyclooxygenase (COX) inhibitors, offering a pathway for safer non-steroidal anti-inflammatory drugs (NSAIDs) with reduced gastrointestinal side effects. Also investigated for antimicrobial properties, particularly against gram-positive bacteria and certain fungal strains. Employed in structure-activity relationship (SAR) studies to optimize triazole-based drug candidates for improved metabolic stability and target selectivity.